[No cross hypersensitivity between molgramostim and filgrastime: apropos of a case].
Chichmanian
R M
RM
Heudier
P
P
Taillan
B
B
Fuzibet
J G
JG
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000276:immunology; D003429:Cross Reactions; D005260:Female; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000276:immunology*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D010267:Parapsoriasis / Q000139:chemically induced; D011994:Recombinant Proteins / Q000009:adverse effects / Q000276:immunology
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; C082430:molgramostim; D000069585:Filgrastim
Absence d'allergie croisée entre molgramostime et filgrastime: à propos d'un cas.